PRINCETON, N.J. — Sandoz acquired the AmLactin family of skin care brands from Upsher-Smith Laboratories. Terms of the transaction were not disclosed.
Under terms of the agreement, Minnesota-based Upsher-Smith, through existing channels, will continue to distribute AmLactin hand and body locations to most U.S. consumers for a 60-day period until it is fully transitioned to Sandoz.
“Adding consumer skin care products to our successful branded and generic pharmaceutical portfolio will enable Sandoz to help even more patients with their skin care needs while continuing to grow a multi-faceted dermatology business,” said Sandoz US President Peter Goldschmidt.